Originally designed to help people manage type 2 diabetes, these medications, such as semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), are now widely recognized for their role in supporting significant weight loss and improving metabolic health
Even so, these stabilized versions generally have shorter shelf lives and higher costs than racemic ALA.42 Liquid ALA Liquid alpha-lipoic acid formulations can improve bioavailability compared to standard solid forms, likely due to faster uptake, potentially making them easier on digestion.54 61 However, liquid ALA requires a bit more care than capsules, like mandatory storage in a cool, dark place ideally, the fridge.55 Liposomal ALA Liposomal ALA alpha-lipoic acid encapsulated in a lipid membrane is a newer delivery form designed to enhance bioavailability and protect ALA from degradation in the digestive tract
Microneedle patches (dissolving, coated, or hollow microneedles typically 300800 um in length) penetrate the stratum corneum and deliver the drug into the viable epidermis or upper dermis
Obviously this is a problem, but in Lyme disease the greater problem is that oxidizing agents and free radicals trigger more production of inflammation chemicals called cytokines
Semaglutide has demonstrated numerous benefits in clinical trials, including: Weight loss Diabetes management Cardioprotective effects Improved overall metabolic health Its remarkable ability to induce significant weight loss has generated considerable interest among medical experts and individuals struggling with weight-related issues
Variations in the GLP1R gene (such as rs6923761) and the GIPR gene (rs1800437) affect receptor density and signaling efficiency, meaning some individuals experience pronounced early symptoms while others feel minimal disruption